PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0090

Crizanlizumab antibody

SELP/CD62

Available by inquiry

Crizanlizumab is a research antibody reference targeting SELP/CD62. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0090
Target
SELP/CD62
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

FDA BLA761128; SPL b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Crizanlizumab Antibody (SELP/CD62) | StellaCyte